Amplitude is based on a new strain of Bacillus amyloliquefaciens discovered by MBI, with strong performance against white molds and soil diseases such as Phytophthora and Rhizoctonia (pink rot and black scurf of potatoes), and Fusarium as shown in field trials in the U.S.,
Growers have few choices of active ingredients that perform well on the group of fungi that cause white molds in row crops like soybeans, canola, pulses, dry beans, bulb vegetables and sunflower. AmplitudeTM is the result of MBI’s directed screening discovery program to find a solution that addresses such a specific market need. This product is also complementary and additive to the broad spectrum of diseases covered by MBI’s first biofungicide, Regalia® Rx , providing a solid one-two punch to controlling white molds and soil diseases in row crops. MBI is also testing this Bacillus-based product for seed treatment applications with key strategic partners.
“We are pleased to provide row crop growers with another tool to control white molds and soil diseases on a broad range of large acre crops and tuber and root crops, which have developed a resistance to conventional products. The high level of performance of Amplitude means it can be used alone, or in conjunction with a conventional fungicide to enhance control, build a solid resistance management program and get better ROI overall,” said
MBI’s unique natural product chemistry approach to product performance is supported by R&D work that demonstrates the bacterium produces natural compounds, some of which inhibit bacterial and fungal growth, as well as spore germination. Tests conducted at MBI’s research and development lab show that Amplitude® works by colonizing plant root hairs, stems and other plant surfaces to prevent establishment of fungal and bacterial pathogens, including Fusarium,Sclerotinia, Rhizoctonia, Verticillium, Phytophthora and Sclerotium. Furthermore, the bacteria trigger systemic acquired resistance and induced systemic responses in the plant, creating a healthier and stronger plant that wards off diseases, increases growth and improves yield. MBI has been issued a patent on the novel strain used in AmplitudeTM.
Field studies have shown good efficacy against Cercospora leaf spot on sugar beets, and white mold on soybean, sunflower, beans, and canola, and soil applications on potatoes for control of Rhizoctonia (Black scurf) and Phytophthora eurythroseptica (pink rot). Successful field trials have been conducted in
The biofungicide product has been submitted to
Amplitude is already available in most states with a few states remaining to be approved. More information is available on the MBI website at https://marronebioinnovations.com/ag-products/brand/amplitude/.
Smart. Natural. Solutions.
Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the potential of Amplitude in the market, market projections, including the potential benefits of Amplitude, and MBI’s plans for expanding additional label uses and international expansion. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company's control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets inside and outside
Marrone Bio Innovations Contacts:
Telephone: +1 (530) 750-2800
MBI External Public Relations:
anthonyBarnum Public Relations
Source: Marrone Bio Innovations